(Press-News.org) New Rochelle, NY, August 13, 2012—Even after being frozen for 18 years, human embryos can be thawed, grown in the laboratory, and successfully induced to produce human embryonic stem (ES) cells, which represent a valuable resource for drug screening and medical research. Prolonged embryonic cryopreservation as an alternative source of ES cells is the focus of an article in BioResearch Open Access, a new bimonthly peer-reviewed open access journal from Mary Ann Liebert, Inc. The article is available free online at the BioResearch Open Access website.
Kamthorn Pruksananonda and coauthors from Chulalongkorn University and Chulalongkorn Memorial Hospital, Bangkok, Thailand, demonstrated that ES cells derived from frozen embryos have a similar ability to differentiate into multiple cell types—a characteristic known as pluripotency—as do ES cells derived from fresh embryos. They present their findings in the article "Eighteen-Year Cryopreservation Does Not Negatively Affect the Pluripotency of Human Embryos: Evidence from Embryonic Stem Cell Derivation."
"The importance of this study is that it identifies an alternative source for generating new embryonic stem lines, using embryos that have been in long-term storage," says Editor-in-Chief Jane Taylor, PhD, MRC Centre for Regenerative Medicine, University of Edinburgh, Scotland.
INFORMATION:
About the Journal
BioResearch Open Access is a bimonthly peer-reviewed open access journal that provides a new rapid-publication forum for a broad range of scientific topics including molecular and cellular biology, tissue engineering and biomaterials, bioengineering, regenerative medicine, stem cells, gene therapy, systems biology, genetics, biochemistry, virology, microbiology, and neuroscience. All articles are published within 4 weeks of acceptance and are fully open access and posted on PubMedCentral. All journal content is available online at the BioResearch Open Access website.
About the Publisher
Mary Ann Liebert, Inc., is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Tissue Engineering, Stem Cells and Development, Human Gene Therapy and HGT Methods, and AIDS Research and Human Retroviruses. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 70 journals, books, and newsmagazines is available at the Mary Ann Liebert, Inc. website.
Mary Ann Liebert, Inc. 140 Huguenot St., New Rochelle, NY 10801-5215 www.liebertpub.com
Phone: (914) 740-2100 (800) M-LIEBERT Fax: (914) 740-2101
Human embryos frozen for 18 years yield viable stem cells suitable for biomedical research
2012-08-13
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Rejected drug may protect against toxic substance common to Alzheimer's and Parkinson's diseases
2012-08-13
The second of two studies on latrepirdine, recently published in Molecular Psychiatry, demonstrates new potential for the compound in the treatment of Alzheimer's disease, Parkinson's disease, sleep disorders, and other neurodegenerative conditions. An international team led by Mount Sinai School of Medicine scientists found that latrepiridine, known commercially as Dimebon, reduced the level of at least two neurodegeneration-related proteins in mice.
Latrepirdine was initially sold as an antihistamine in Russia, following its approval for use there in 1983. In the 1990s, ...
Diabetes drugs taken by over 15 million Americans raises risk of bladder cancer
2012-08-13
PHILADELPHIA -- A popular class of diabetes drugs increases patients' risk of bladder cancer, according to a new study published online this month in the Journal of the National Cancer Institute. Researchers from the Perelman School of Medicine at the University of Pennsylvania found that patients taking thiazolidinedione (TZDs) drugs – which account for up to 20 percent of the drugs prescribed to diabetics in the United States -- are two to three times more likely to develop bladder cancer than those who took a sulfonylurea drug, another common class of medications for ...
Mount Sinai researchers identify new drug target for schizophrenia
2012-08-13
Researchers at Mount Sinai School of Medicine may have discovered why certain drugs to treat schizophrenia are ineffective in some patients. Published online in Nature Neuroscience, the research will pave the way for a new class of drugs to help treat this devastating mental illness, which impacts one percent of the world's population, 30 percent of whom do not respond to currently available treatments.
A team of researchers at Mount Sinai School of Medicine set out to discover what epigenetic factors, or external factors that influence gene expression, are involved in ...
Existing drugs offer new treatment options for high-risk childhood leukemia subtype
2012-08-13
Scientists have identified new genetic alterations underlying a high-risk subtype of the most common childhood cancer that could be effectively targeted with existing leukemia therapies.
The study focused on a subtype of acute lymphoblastic leukemia (ALL) known as Philadelphia chromosome-like ALL (Ph-like ALL). This subgroup accounts for as much as 15 percent of childhood ALL that is associated with a high risk of relapse and a poor outcome. The genetic changes driving the disease were previously unknown for about half of all patients with Ph-like ALL. The work identified ...
Are methane hydrates dissolving?
2012-08-13
The average temperatures of the atmosphere are rising; the average temperatures of the oceans, too. Not only living organisms react sensititvely to these changes. The transitional zones between shallow shelf seas and the deep sea at continental slopes store a huge amount of methane hydrates in the sea bed. These specific, ice-like compounds only forms at low temperatures and under high pressure. When the water temperature directly above the sea bed rises, some of the methane hydrates could dissolve and release the previously bound methane. "This scenario incorporates two ...
Scientists use light to 'tag and track' genetic processes
2012-08-13
In a new study, UT Dallas researchers outline how they used fluorescent molecules to "tag" DNA and monitor a process called DNA looping, a natural biological mechanism involved in rearranging genetic material in some types of cells.
The UT Dallas "tag and track" method not only sheds light on how DNA loops form, but also might be adapted to screen drugs for effectiveness against certain viruses that shuffle genetic material, such as HIV.
Until now, scientists primarily had "snapshots" of the initial and final stages of DNA loop formation, with only limited information ...
Consumers perceive risk when 'price' means more than money
2012-08-13
When companies combine different pricing structures – such as asking for effort or information in combination with or instead of money – consumers perceive a greater risk in the decision to buy.
That's according to University of Cincinnati research to be presented at the Aug. 15-17 Behavioral Pricing Conference in Detroit, Mich., by doctoral marketing student John Dinsmore. His paper is titled "Mental Accounting, General Evaluability Theory and the Framing Losses Posed by Partitioned Monetary and Nonmonetary Prices."
According to Dinsmore, shoppers routinely arrive ...
Butter flavoring in microwave popcorn, thought safe for food industry workers, is respiratory hazard
2012-08-13
Philadelphia, PA, August 13, 2012 – The ingredient 2,3-pentanedione (PD), used to impart the flavor and aroma of butter in microwave popcorn, is a respiratory hazard that can also alter gene expression in the brain of rats. Manufacturers started using PD when another butter flavoring, diacetyl, was found to cause bronchiolitis obliterans, a life-threatening and nonreversible lung disease in workers who inhaled the substance. New research on PD with implications for "popcorn workers' lung" is published in The American Journal of Pathology and indicates that acute PD exposure ...
Optics and photonics research priorities, grand challenges presented in new report
2012-08-13
WASHINGTON — A new report from the National Research Council identifies research priorities and grand challenges to fill gaps in optics and photonics, a field that has the potential to advance the economy of the United States and provide visionary directions for future technology applications. The report recommends that the federal government develop a "National Photonics Initiative" to bring together academia, industry, and government to steer federal research and development funding and activities.
"Much is unknown when pursuing basic optical science and its transition ...
Researchers identify key culprit causing muscle atrophy
2012-08-13
Whether you're old, have been ill, or suffered an injury, you've watched gloomily as your muscles have atrophied. The deterioration of muscle—even slight or gradual—is about as common to the human condition as breathing.
Yet despite its everyday nature, scientists know little about what causes skeletal muscles to atrophy. They know proteins are responsible, but there are thousands of possible suspects, and parsing the key actors from the poseurs is tricky.
In a new paper, researchers from the University of Iowa report major progress. The team has identified a single ...